RheoGene Names Hood, Ashburner to Scientific Advisory Board | GenomeWeb

NEW YORK, May 30 – RheoGene, a privately held gene expression company based in Charlottesville, Va., announced Wednesday that it had appointed several genomics industry heavyweights to its scientific advisory board.

Michael Ashburner, the joint head of the European Molecular Biology Laboratory and the European Bioinformatics Institute, and Leroy Hood, director of the Institute for Systems Biology, were both named to the board as was Jeffrey Trent, scientific director of the National Human Genome Research Institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.